VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $376,716,000 | +7.1% | 16,209,833 | -26.7% | 0.13% | +3.2% |
| Q1 2018 | $351,906,000 | -23.8% | 22,104,604 | -0.5% | 0.12% | -23.3% |
| Q4 2017 | $461,713,000 | +66.6% | 22,219,117 | +14.9% | 0.16% | +52.3% |
| Q3 2017 | $277,178,000 | -24.9% | 19,342,590 | -9.3% | 0.11% | -33.5% |
| Q2 2017 | $369,140,000 | +88.1% | 21,337,539 | +19.9% | 0.16% | +61.0% |
| Q1 2017 | $196,244,000 | -34.3% | 17,791,783 | -13.5% | 0.10% | -33.8% |
| Q4 2016 | $298,651,000 | -30.0% | 20,568,285 | +18.4% | 0.15% | -26.7% |
| Q3 2016 | $426,394,000 | +19.1% | 17,368,388 | -2.3% | 0.21% | +7.3% |
| Q2 2016 | $358,120,000 | -45.1% | 17,781,570 | -28.2% | 0.19% | -44.7% |
| Q1 2016 | $651,756,000 | -51.2% | 24,781,560 | +88.5% | 0.35% | -43.9% |
| Q4 2015 | $1,336,637,000 | +46.9% | 13,149,401 | +157.8% | 0.62% | +57.3% |
| Q3 2015 | $909,690,000 | +45.0% | 5,099,734 | +80.6% | 0.39% | +47.2% |
| Q2 2015 | $627,382,000 | -2.4% | 2,824,138 | -12.8% | 0.27% | -8.2% |
| Q1 2015 | $643,021,000 | +21.7% | 3,237,445 | -12.3% | 0.29% | +38.6% |
| Q4 2014 | $528,276,000 | +4.8% | 3,691,400 | -3.9% | 0.21% | +7.7% |
| Q3 2014 | $504,069,000 | +41.9% | 3,841,977 | +36.4% | 0.20% | +26.6% |
| Q2 2014 | $355,237,000 | -5.9% | 2,816,662 | -1.7% | 0.15% | -12.0% |
| Q1 2014 | $377,671,000 | +44.0% | 2,864,831 | +28.3% | 0.18% | +44.6% |
| Q4 2013 | $262,193,000 | +114.5% | 2,233,335 | +90.6% | 0.12% | +89.1% |
| Q3 2013 | $122,261,000 | -34.3% | 1,171,867 | -45.8% | 0.06% | -39.0% |
| Q2 2013 | $186,048,000 | – | 2,161,346 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |